Cargando…
Adherence to Iron Chelation Therapy and Its Determinants
Background: Thalassemia is a chronic disease requiring lifelong treatment. The adherence to regular iron chelation therapy is important to ensure complication-free survival and good quality of life. The study aim to assess the adherence to iron chelation therapy (ICT) in patients with transfusion-de...
Autores principales: | Sidhu, Sukhmani, Kakkar, Shruti, Dewan, Priyanka, Bansal, Namita, Sobti, Praveen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885136/ https://www.ncbi.nlm.nih.gov/pubmed/33613898 http://dx.doi.org/10.18502/ijhoscr.v15i1.5247 |
Ejemplares similares
-
COVID 19 pandemic and lockdown: A double whammy for patients with thalassemia
por: Kakkar, Shruti, et al.
Publicado: (2021) -
Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
por: Chong, Chia Chee, et al.
Publicado: (2021) -
Effect of drug use calendar on adherence to iron chelation therapy in young thalassemia patients
por: Chawsamtong, Sriwatree, et al.
Publicado: (2022) -
Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia
por: Mohamed, Rafaa, et al.
Publicado: (2022) -
Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
por: Eziefula, Chinea, et al.
Publicado: (2022)